+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genentech, Inc.  - logo

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

Trastuzumab-Biosimilars Insight, 2022 - Product Thumbnail Image

Trastuzumab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 125 Pages
  • Global
From
Immuno-oncology Market - Product Thumbnail Image

Immuno-oncology Market

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
From
Eye Melanoma Market Report 2025 - Product Thumbnail Image

Eye Melanoma Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
From
From
Retinal Biologics Market Report 2025 - Product Thumbnail Image

Retinal Biologics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Plasminogen Activators - Pipeline Insight, 2025 - Product Thumbnail Image

Plasminogen Activators - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator